CDLX
Cardlytics Inc
Cardlytics Inc historical holders
total: 3
Oakcliff Capital Partners Cardlytics Inc transactions over time
- Total transactions:
- 8
- New positions:
- 1
- Sold out:
- 1
- Added:
- 4
- Reduced:
- 2
- Held since:
- 2019 Q3
- Held for:
- 12 quarters
- Latest activity:
- 2022 Q3
Bryan R. Lawrence has been an institutional investor in Cardlytics Inc (CDLX) since 2019 Q3. According to 2026 Q1 report, Bryan R. Lawrence doesn't hold any shares. The fund/company first acquired CDLX in 2019 Q3, initially purchasing 28,106 shares. Since the initial investment, Oakcliff Capital Partners has made 7 more transactions in this position.
When did Bryan R. Lawrence exit their CDLX position?
Bryan R. Lawrence no longer holds Cardlytics Inc (CDLX). They sold off their entire position in 2022 Q3, closing out an investment that began in 2019 Q3.
When did Bryan R. Lawrence first invest in CDLX?
Bryan R. Lawrence first invested in Cardlytics Inc (CDLX) in 2019 Q3 at the reported quarter-end price of $335.19 per share, acquiring 28,106 shares in their initial purchase.
What is Bryan R. Lawrence's average cost basis for CDLX?
Based on historical transaction data, Bryan R. Lawrence's estimated cost basis for Cardlytics Inc (CDLX) is approximately $393.23 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $393.23
- Weighted AVG sell price:
- $464.00
CDLX transactions history by Oakcliff Capital Partners
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q3
|
0.00%
|
0
|
$223.11
|
|
-100% (-33,973.6)
|
-5.59%
|
|
2022 Q2
|
5.59%
|
33,973.6
|
$223.11
|
$7,580,000
|
+11.49% (+3,500)
|
+0.58%
|
|
2021 Q4
|
9.20%
|
30,473.6
|
$660.90
|
$20,140,000
|
+12.26% (+3,328.9)
|
+1.01%
|
|
2021 Q3
|
10.09%
|
27,144.7
|
$839.39
|
$22,785,000
|
+14.80% (+3,500)
|
+1.3%
|
|
2021 Q1
|
12.30%
|
23,644.7
|
$1,096.99
|
$25,938,000
|
-12.39% (-3,344.8)
|
-1.46%
|
|
2020 Q4
|
15.30%
|
$1,427.70
|
-18.91% (-6,295)
|
|||
|
2020 Q1
|
8.14%
|
$349.59
|
+18.42% (+5,178.1)
|
|||
|
2019 Q3
|
6.37%
|
$335.19
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.